Hiroshi Maeda - defining the pathway to targeted cancer therapy

ISSN： 1061-186X

Source： Journal of Drug Targeting, Vol.15, Iss.7-8, 2007-08, pp. : 456-456

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeted therapy of hepatocellular cancer

By Wysocki Piotr Jan

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 2, 2010-02 ,pp. : 265-274

Informa Healthcare

Access to resources Recommend Favorite

Endoglin-Targeted Cancer Therapy

Current Drug Delivery, Vol. 8, Iss. 1, 2011-01 ,pp. : 135-143

Bentham Science Publishers

Access to resources Recommend Favorite

Targeted Therapy of Breast Cancer

Current Pharmaceutical Design, Vol. 13, Iss. 5, 2007-02 ,pp. : 497-517

Bentham Science Publishers

Access to resources Recommend Favorite

Targeted Therapy for Advanced Prostate Cancer: Inhibition of the PI3K/Akt/mTOR Pathway

Current Cancer Drug Targets, Vol. 9, Iss. 2, 2009-03 ,pp. : 237-249

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial: In honour of Professor Hiroshi Maeda, Recipient of the Journal of Drug Targeting's Life-time Achievement Award for 2007

By Akhtar Saghir

Journal of Drug Targeting, Vol. 15, Iss. 7-8, 2007-08 ,pp. : 455-455

Informa Healthcare

Access to resources Recommend Favorite